| Postresection surveillance for pancreatic cancer performance status, imaging, and serum markers. | |
| | |
MedLine Citation:
|
PMID: 23187849 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
ABSTRACT: Approximately 15% of patients with a diagnosis of pancreatic adenocarcinoma are candidates for potentially curative surgery. However, most patients who undergo such surgery will die from recurrent disease, most within the first few years, whereas nearly all succumb by 5 to 7 years from diagnosis. Currently, there is a lack of high-level evidence to guide consensus recommendations as to the optimal surveillance strategy after resection. There is considerable variability in clinical practice, ranging from frequent clinical follow-up, with serial Ca 19-9 measurement and routine computed tomographic imaging on a 3- to 6-monthly basis, to a practice of no routine serum or imaging follow-up after surgery. In most part, this divergence in practice reflects a lack of data to define optimal practice. The argument in favor of limited surveillance presumably stems from the relatively uniform poor outcomes after recurrence and the absence of evidence indicating that early detection of local, regional, or metastatic recurrence improves outcomes. However, recent advancements in the treatment of metastatic disease offer hope that earlier detection and initiation of treatment for recurrent disease may positively impact clinical outcomes and at least urges review of the topic. One advantage to the development of defined guidelines would be greater consistency in the setting of both routine clinical follow-up and follow-up after adjuvant therapy on trial. |
| | |
Authors:
|
Eileen M O'Reilly; Maeve A Lowery |
Related Documents
:
|
23020209 - Independent predictors of survival and the impact of repeat surgery in patients undergo... 22054889 - A decade of advances in treatment of early-stage lung cancer. 23052739 - Clinical outcome of up-front surgery in patients with asymptomatic, incurable synchrono... 8980989 - Radiation pneumonitis complicating mediastinal radiotherapy postpneumonectomy. 21773909 - Stromal sarcoma of the breast with lung metastases showing a clinical complete response... 2460169 - Toxicity of a combination of abvd chemotherapy and mediastinal irradiation for hodgkin'... 21508399 - High-risk group for locoregional recurrence in patients with stage ib-iib squamous cell... 20390419 - A phase i/ii trial of the oral antiangiogenic agent tsu-68 in patients with advanced he... 712899 - Squamous cell carcinoma of the bladder. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Cancer journal (Sudbury, Mass.) Volume: 18 ISSN: 1540-336X ISO Abbreviation: Cancer J Publication Date: 2012 Nov |
Date Detail:
|
Created Date: 2012-11-28 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100931981 Medline TA: Cancer J Country: United States |
Other Details:
|
Languages: eng Pagination: 609-13 Citation Subset: IM |
Affiliation:
|
From the *Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and Weill Medical College of Cornell University, New York, NY; and †Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A neoadjuvant strategy for the management of nonmetastatic pancreatic cancer.
Next Document: Postresection chemotherapy for pancreatic cancer.